|
LOC645676 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11959996829114E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.44733180574531E-12 |
| Normal-vs-Stage2 |
2.142300E-02 |
| Normal-vs-Stage3 |
7.38080041529088E-10 |
| Normal-vs-Stage4 |
9.62199999676727E-08 |
| Stage1-vs-Stage2 |
1.311960E-01 |
| Stage1-vs-Stage3 |
9.742400E-01 |
| Stage1-vs-Stage4 |
9.291000E-01 |
| Stage2-vs-Stage3 |
1.417570E-01 |
| Stage2-vs-Stage4 |
1.802240E-01 |
| Stage3-vs-Stage4 |
9.155800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.59521309892352E-13 |
| Normal-vs-AfricanAmerican |
2.624500E-03 |
| Normal-vs-Asian |
1.1959000456585E-10 |
| Caucasian-vs-AfricanAmerican |
8.373600E-02 |
| Caucasian-vs-Asian |
2.316800E-01 |
| AfricanAmerican-vs-Asian |
1.275880E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.6646999879153E-09 |
| Normal-vs-Female |
4.93060037243254E-10 |
| Male-vs-Female |
7.995000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65867319878998E-12 |
| Normal-vs-Age(41-60Yrs) |
5.58790003157839E-09 |
| Normal-vs-Age(61-80Yrs) |
3.05050000004581E-06 |
| Normal-vs-Age(81-100Yrs) |
3.639200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.318400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.446300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.709000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.292400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.303000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.578600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.001400E-03 |
| Classical-VS-Follicular |
7.422300E-02 |
| Classical-VS-Other |
8.553400E-01 |
| Classical-VS-Normal |
8.66895444318061E-12 |
| Tall-VS-Follicular |
2.012600E-04 |
| Tall-VS-Other |
6.835800E-02 |
| Tall-VS-Normal |
5.43950440246022E-11 |
| Follicular-VS-Other |
4.380600E-01 |
| Follicular-VS-Normal |
6.441400E-04 |
| Other-VS-Normal |
1.228310E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.66069996327445E-09 |
| Normal-vs-N1 |
3.12790000012164E-07 |
| N0-vs-N1 |
3.636400E-01 |
|
|
